PLA2G2E | Phospholipase A2, group IIE | Enzymes Predicted secreted proteins RAS pathway related proteins
| | | | | Not detected |
PLA2G2F | Phospholipase A2, group IIF | Enzymes Predicted membrane proteins RAS pathway related proteins
| | | | | Group enriched |
PLA2G3 | Phospholipase A2, group III | Enzymes Predicted secreted proteins RAS pathway related proteins
| | | | | Group enriched |
PLA2G4A | Phospholipase A2, group IVA (cytosolic, calcium-dependent) | Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Mixed |
PLA2G4B | Phospholipase A2, group IVB (cytosolic) | Enzymes RAS pathway related proteins
| | | | | Expressed in all |
PLA2G4C | Phospholipase A2, group IVC (cytosolic, calcium-independent) | Enzymes RAS pathway related proteins
| | | | | Mixed |
PLA2G4D | Phospholipase A2, group IVD (cytosolic) | Enzymes RAS pathway related proteins
| | | | | Group enriched |
PLA2G4E | Phospholipase A2, group IVE | RAS pathway related proteins
| | | | | Tissue enriched |
PLA2G4F | Phospholipase A2, group IVF | Enzymes RAS pathway related proteins
| | | | | Group enriched |
PLA2G5 | Phospholipase A2, group V | Disease related genes Enzymes Potential drug targets Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PLA2G6 | Phospholipase A2, group VI (cytosolic, calcium-independent) | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins RAS pathway related proteins
| | | | | Expressed in all |
PLCE1 | Phospholipase C, epsilon 1 | Disease related genes Enzymes Plasma proteins Potential drug targets RAS pathway related proteins
| | | | | Mixed |
PLCG1 | Phospholipase C, gamma 1 | Cancer-related genes Enzymes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
PLCG2 | Phospholipase C, gamma 2 (phosphatidylinositol-specific) | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets RAS pathway related proteins
| | | | | Mixed |
PLD1 | Phospholipase D1, phosphatidylcholine-specific | Enzymes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
PLD2 | Phospholipase D2 | Enzymes RAS pathway related proteins
| | | | | Expressed in all |
PRKACA | Protein kinase, cAMP-dependent, catalytic, alpha | Enzymes RAS pathway related proteins
| | | | | Expressed in all |
PRKACB | Protein kinase, cAMP-dependent, catalytic, beta | Enzymes RAS pathway related proteins
| | | | | Expressed in all |
PRKACG | Protein kinase, cAMP-dependent, catalytic, gamma | Enzymes RAS pathway related proteins
| | | | | Tissue enriched |
PRKCA | Protein kinase C, alpha | Cancer-related genes Enzymes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
PRKCB | Protein kinase C, beta | Cancer-related genes Enzymes Plasma proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PRKCG | Protein kinase C, gamma | Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Tissue enriched |
PRKX | Protein kinase, X-linked | Disease related genes Enzymes Plasma proteins Potential drug targets RAS pathway related proteins
| | | | | Mixed |
PTPN11 | Protein tyrosine phosphatase, non-receptor type 11 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
RAB5A | RAB5A, member RAS oncogene family | RAS pathway related proteins
| | | | | Expressed in all |
RAB5B | RAB5B, member RAS oncogene family | RAS pathway related proteins
| | | | | Expressed in all |
RAB5C | RAB5C, member RAS oncogene family | Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
RAC1 | Ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | Cancer-related genes RAS pathway related proteins
| | | | | Expressed in all |
RAC2 | Ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | Disease related genes RAS pathway related proteins
| | | | | Expressed in all |
RAC3 | Ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) | RAS pathway related proteins
| | | | | Mixed |
RAF1 | V-raf-1 murine leukemia viral oncogene homolog 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
RALA | V-ral simian leukemia viral oncogene homolog A (ras related) | RAS pathway related proteins
| | | | | Expressed in all |
RALB | V-ral simian leukemia viral oncogene homolog B | RAS pathway related proteins
| | | | | Expressed in all |
RALBP1 | RalA binding protein 1 | RAS pathway related proteins Transporters
| | | | | Expressed in all |
RALGDS | Ral guanine nucleotide dissociation stimulator | Cancer-related genes Predicted secreted proteins RAS pathway related proteins
| | | | | Expressed in all |
RAP1A | RAP1A, member of RAS oncogene family | RAS pathway related proteins
| | | | | Expressed in all |
RAP1B | RAP1B, member of RAS oncogene family | Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
RAPGEF5 | Rap guanine nucleotide exchange factor (GEF) 5 | Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
RASA1 | RAS p21 protein activator (GTPase activating protein) 1 | Cancer-related genes Disease related genes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
RASA2 | RAS p21 protein activator 2 | Predicted secreted proteins RAS pathway related proteins
| | | | | Expressed in all |
RASA3 | RAS p21 protein activator 3 | Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
RASA4 | RAS p21 protein activator 4 | Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
RASA4B | RAS p21 protein activator 4B | RAS pathway related proteins
| | | | | Tissue enhanced |
RASAL1 | RAS protein activator like 1 (GAP1 like) | Plasma proteins RAS pathway related proteins
| | | | | Tissue enhanced |
RASAL2 | RAS protein activator like 2 | Plasma proteins RAS pathway related proteins
| | | | | Mixed |
RASAL3 | RAS protein activator like 3 | RAS pathway related proteins
| | | | | Tissue enhanced |
RASGRF1 | Ras protein-specific guanine nucleotide-releasing factor 1 | RAS pathway related proteins
| | | | | Group enriched |
RASGRF2 | Ras protein-specific guanine nucleotide-releasing factor 2 | RAS pathway related proteins
| | | | | Mixed |
RASGRP1 | RAS guanyl releasing protein 1 (calcium and DAG-regulated) | Disease related genes RAS pathway related proteins
| | | | | Mixed |
RASGRP2 | RAS guanyl releasing protein 2 (calcium and DAG-regulated) | Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |